Amlodipine Besylate Tablet
Product Images NDC 67296-2297

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 67296-2297). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container-label-10mg-90s (Container Label 10mg 90s)

Amlodipine Besylate 10 mg tablets, USP oral dosage form label from Cipla. The label states that each tablet contains amlodipine besylate equivalent to 10 mg of amlodipine. It includes directions for use, storage instructions, and manufacturer information. The package size is 90 tablets, and the labeler is Cipla USA, Inc. The label also displays the NDC 69097-128-05 and a barcode.*

FDA Label Image

Container-label-2pt5mg-90s (Container Label 2pt5mg 90s)

A packaging label for Amlodipine Besylate Tablets, USP 2.5 mg by Redpharm Drug, containing 90 tablets. The label includes dosage strength, manufacturer information (Cipla Ltd. in India and Cipla USA, Inc.), storage instructions, a barcode, and a note for pharmacists to dispense with the patient leaflet.*

FDA Label Image

Container-label-5mg-90s (Container Label 5mg 90s)

A medication label for Amlodipine Besylate Tablets, USP, 5 mg strength in tablet form. The label indicates a package of 90 tablets and includes manufacturer information for Cipla Ltd. and Cipla USA, Inc. It also notes dispensing instructions and storage conditions, and displays the NDC 69097-127-05 barcode.*

FDA Label Image

Figure-1 (Figure 1)

A Kaplan-Meier curve comparing event rates over 24 months between Amlodipine and Placebo groups. The x-axis represents time in months, and the y-axis shows event rate. The plot includes a legend box showing a p-value of 0.003, hazard ratio of 0.691, and 95% confidence interval of 0.54 to 0.88. Numbers at risk are indicated below the x-axis at various time points.*

FDA Label Image

Figure-2 (Figure 2)

A forest plot illustrating the hazard ratios with 95% confidence intervals for various patient subgroups comparing Amlodipine versus placebo. Subgroups include overall patients, age groups (<65 and ≥65), gender, baseline sitting systolic blood pressure, baseline vessel disease, baseline vessels with stenosis, and PCI-stent strata with numerical sample sizes indicated. The plot's x-axis ranges from 0.0 to 2.0.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of amlodipine besylate showing its molecular framework with labeled atoms and chemical bonds, including chlorine and amino groups, consistent with the active ingredient amlodipine besylate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.